DiaMedica Therapeutics Inc. (DMAC) Net Income (Loss) Attributable to Parent USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
DiaMedica Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2024.
  • DiaMedica Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$5.15 M, a 2.3% increase year-over-year.
  • DiaMedica Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$19.3 M, a 24.7% decline year-over-year.
  • DiaMedica Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$19.4 M, a 41.7% decline from 2022.
  • DiaMedica Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$13.7 M, a 0.62% decline from 2021.
  • DiaMedica Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$13.6 M, a 10.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$19.3 M -$5.15 M +$121 K +2.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$19.4 M -$5.16 M -$1.41 M -37.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 -$18 M -$4.47 M -$1.41 M -46.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$16.6 M -$4.48 M -$1.12 M -33.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-13
Q1 2023 -$15.4 M -$5.27 M -$1.76 M -50.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$13.7 M -$3.75 M -$505 K -15.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$13.2 M -$3.06 M +$391 K +11.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$13.6 M -$3.36 M -$84 K -2.57% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$13.5 M -$3.51 M +$114 K +3.15% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$13.6 M -$3.25 M +$954 K +22.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$14.5 M -$3.45 M -$257 K -8.05% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$14.3 M -$3.27 M -$800 K -32.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 -$13.5 M -$3.62 M -$1.2 M -49.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q4 2020 -$12.3 M -$4.2 M -$1.72 M -69.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 -$10.6 M -$3.19 M -$745 K -30.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$9.83 M -$2.47 M -$5 K -0.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$9.82 M -$2.43 M +$827 K +25.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$10.6 M -$2.48 M -$518 K -26.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-10
Q3 2019 -$10.1 M -$2.45 M -$1.06 M -76.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$9.07 M -$2.47 M -$734 K -42.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-04
Q1 2019 -$8.34 M -$3.25 M -$2.6 M -400% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-04
Q4 2018 -$5.73 M -$1.96 M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-23
Q3 2018 -$1.39 M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$1.74 M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$650 K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.